Completed
Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01961765
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States